Abstract
Ageing-dependent dysfunctions develop for each of various cell types in living organisms. Amongst them, immunosenescence, an ageing-dependent deterioration of the immune system, seriously affects the health condition of an aged individual. The central problem in immunosenescence is a decrease in the ability of T-cells to respond to antigens for proliferation and cytokine production, accompanied by accumulation of T-cells with a memory cell phenotype (CD44-high CD45RB-low) replacing those with a naïve cell phenotype (CD44-low CD45RB-high). Recently, a transgenic mouse model and a genetically modified mouse model have been reported to display promoted immunosenescence. One is a mouse line transgenic to human CD2 promoter / enhancer-guided rabbit protein kinase C(PKC)α, and the other is a mouse line in which the p53 gene is deficient (p53- / -). Both of these mouse lines display accelerated accumulation of memory Tcell replacing naïve T-cells during ageing, accompanying progressively diminishing responsiveness to sheep red blood cell antigens for cytokine production. T-cells activate PKCα when they receive either an antigenic or stress stimulus. Repetitions of antigenic and stress stimuli that recurrently activate PKCα are probably mimicked by continuously elevated PKCα activity in the PKCα transgenic mice. Activated PKC-α probably counteracts the apoptosis-inducing signal, which prevents activation-induced cell death of T-cells and causes accumulation of memory T-cells as the descendants of activated T-cells that have survived. On the other hand, p53 is known to mediate the signaling for apoptosis induction that follows DNA damage due to oxidative stress. The apoptotic signal pathway fails to work well in p53- / - mice. During ageing of these mice, T-cells must encounter a number of antigenic and stress stimuli for activation, and activation of Tcells that is not followed by cell-death causes accumulation of memory T-cells. Results of experiments using the two transgenic mouse models for immunosenescence introduced here support the view that immunosenescence develops by chronic exposure to antigenic and stress stimuli, which is promoted by a defect in the mechanism for efficient elimination of activated T-cells.
Keywords: transgenic mouse models, Immunosenescence, cytokine production, memory cell phenotype, naive cell phenotype, memory t-cells, stress stimuli
Current Genomics
Title: Transgenic Mouse Models for Immunosenescence
Volume: 4 Issue: 5
Author(s): Izumi Nakashima, Jun Du, Toshihiro Yokoyama, Yoshiyuki Kawamoto, Kozo Ohkusu-Tsukada and Ken-ichi Isobe
Affiliation:
Keywords: transgenic mouse models, Immunosenescence, cytokine production, memory cell phenotype, naive cell phenotype, memory t-cells, stress stimuli
Abstract: Ageing-dependent dysfunctions develop for each of various cell types in living organisms. Amongst them, immunosenescence, an ageing-dependent deterioration of the immune system, seriously affects the health condition of an aged individual. The central problem in immunosenescence is a decrease in the ability of T-cells to respond to antigens for proliferation and cytokine production, accompanied by accumulation of T-cells with a memory cell phenotype (CD44-high CD45RB-low) replacing those with a naïve cell phenotype (CD44-low CD45RB-high). Recently, a transgenic mouse model and a genetically modified mouse model have been reported to display promoted immunosenescence. One is a mouse line transgenic to human CD2 promoter / enhancer-guided rabbit protein kinase C(PKC)α, and the other is a mouse line in which the p53 gene is deficient (p53- / -). Both of these mouse lines display accelerated accumulation of memory Tcell replacing naïve T-cells during ageing, accompanying progressively diminishing responsiveness to sheep red blood cell antigens for cytokine production. T-cells activate PKCα when they receive either an antigenic or stress stimulus. Repetitions of antigenic and stress stimuli that recurrently activate PKCα are probably mimicked by continuously elevated PKCα activity in the PKCα transgenic mice. Activated PKC-α probably counteracts the apoptosis-inducing signal, which prevents activation-induced cell death of T-cells and causes accumulation of memory T-cells as the descendants of activated T-cells that have survived. On the other hand, p53 is known to mediate the signaling for apoptosis induction that follows DNA damage due to oxidative stress. The apoptotic signal pathway fails to work well in p53- / - mice. During ageing of these mice, T-cells must encounter a number of antigenic and stress stimuli for activation, and activation of Tcells that is not followed by cell-death causes accumulation of memory T-cells. Results of experiments using the two transgenic mouse models for immunosenescence introduced here support the view that immunosenescence develops by chronic exposure to antigenic and stress stimuli, which is promoted by a defect in the mechanism for efficient elimination of activated T-cells.
Export Options
About this article
Cite this article as:
Nakashima Izumi, Du Jun, Yokoyama Toshihiro, Kawamoto Yoshiyuki, Ohkusu-Tsukada Kozo and Isobe Ken-ichi, Transgenic Mouse Models for Immunosenescence, Current Genomics 2003; 4 (5) . https://dx.doi.org/10.2174/1389202033490312
DOI https://dx.doi.org/10.2174/1389202033490312 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Restoration of Antitumor Immunity Through Selective Inhibition of Myeloid Derived Suppressor Cells by Anticancer Therapies
Current Molecular Medicine Nonviral Approach for Targeted Nucleic Acid Delivery
Current Medicinal Chemistry CD95 Signaling in Cancer Treatment
Current Pharmaceutical Design Chemokines and Brain Functions
Current Drug Targets - Inflammation & Allergy Prospects of miRNA-Based Therapy for Pancreatic Cancer
Current Drug Targets IO Nation: The Rise of Immuno-Oncology
Current Pharmacogenomics and Personalized Medicine Pharmacologic Ovarian Preservation in Young Women Undergoing Chemotherapy
Current Medicinal Chemistry Anticancer Activity of the Ascidian Polyclinum Indicum against Cervical Cancer Cells (HeLa) Mediated through Apoptosis Induction
Medicinal Chemistry Characterization of Molecular and Functional Alterations of Tumor Endothelial Cells to Design Anti-Angiogenic Strategies
Current Vascular Pharmacology Curcumin: A Promising Agent Targeting Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews Clinical Use of Rituximab in Patients with HIV Related Lymphoma and Multicentric Castlemans Disease
Current Drug Delivery Serum S-100B Protein as A Biochemical Marker of Brain Injury: A Review of Current Concepts
Current Medicinal Chemistry Bcl-2 Proteins: Targets and Tools for Chemosensitisation of Tumor Cells
Current Medicinal Chemistry - Anti-Cancer Agents The Transcriptome in Blood: Challenges and Solutions for Robust Expression Profiling
Current Molecular Medicine Free Fatty Acids: Circulating Contributors of Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry AMPK As A Target in Rare Diseases
Current Drug Targets MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges
Current Cancer Drug Targets Expanding Targets for a Metabolic Therapy of Cancer: L-Asparaginase
Recent Patents on Anti-Cancer Drug Discovery The Role of Melatonin in Pancreatic Protection: Could Melatonin be Used in the Treatment of Acute Pancreatitis?
Current Pharmaceutical Design